Charles Schwab Investment Management Inc. Invests $2.73 Million in Bicara Therapeutics Inc. (NASDAQ:BCAX)
Charles Schwab Investment Management Inc. bought a new position in shares of Bicara Therapeutics Inc. (NASDAQ:BCAX – Free Report) in the fourth quarter, Holdings Channel reports. The firm bought 156,784 shares of the company’s stock, valued at approximately $2,731,000. A number of other institutional investors and hedge funds have also recently bought and sold shares […]
